The aim of the study is to evaluate the prevalence and bring awareness of cardiovascular complications in COVID-19 recovered patients.~Objectives of the study:~To study causes and risk factors of cardiac disorders associated with COVID-19~To identify different types of cardiac symptoms patients, present with~To study the impact of co-morbidities on COVID-19 recovered patients~To study treatment patterns and duration of therapy~Plan to study:~To select the patient based on inclusion and exclusion criteria~To collect the patient information from case sheets and by patient interaction~To identify different types of cardiac disorders related to COVID-19 or its treatment regimen~To study the management of COVID-19 complication and related cardiovascular disorders~Study Sites: Srinivasa Heart Centre, Warangal (T.S) Study Design: Observational cohort study Study Duration: 4 months~Subject Eligibility:~Inclusion Criteria~Patients who are willing to participate~Patients having previous COVID-19 treatment record~Prescriptions reported during the study period~The prescription which is legible and complete~Exclusion Criteria~Patients who are not willing to participate~The patient having no history of COVID-19 and available data~Source of the data:~Review of patient case sheet, prescription and lab reports~Personal interaction with patients and caregivers~Sample size: 500 Patients
Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.